Investor Relations

Establish A Purpose, Strategy And Business Model Which Promote Long-Term Value For Shareholders (QCA Principle 1)

The Board is responsible for setting the Company’s strategy and ensuring that appropriate controls, decision-making processes and resources are in place to deliver long-term shareholder value. Following a strategic review in late 2025, CelLBxHealth has repositioned its business towards a commercially focused, partner-led model centred on product sales, laboratory services and the development of laboratory-developed tests. The strategy prioritizes revenue growth, cost discipline and the expansion of strategic partnerships, particularly in the United States and other key markets.

Request a meeting with






    CelLBxHealth Logo
    Privacy overview

    This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.